Physiologically based pharmacokinetic (PBPK) modeling: It is here to stay!

被引：21
|
作者：
Rostami-Hodjegan, Amin [1 ]
Tamai, Ikumi [2 ]
Pang, K. Sandy [3 ]
机构：
[1] Univ Manchester, Manchester M13 9PL, Lancs, England
[2] Kanazawa Univ, Kanazawa, Ishikawa 9201192, Japan
[3] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 1A1, Canada
来源：
BIOPHARMACEUTICS & DRUG DISPOSITION | 2012年 / 33卷 / 02期
关键词：
D O I：
10.1002/bdd.1776
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：47 / 50
页数：4
相关论文
共 50 条
  • [41] Determination of the rat tissue partitioning of endotoxin in vitro for physiologically-based pharmacokinetic (PBPK) modeling
    Ross, IA
    Sapienza, PP
    Hanes, DE
    Johnson, W
    Kim, CS
    JOURNAL OF APPLIED TOXICOLOGY, 2004, 24 (03) : 177 - 181
  • [42] Current and future physiologically based pharmacokinetic (PBPK) modeling approaches to optimize pharmacotherapy in preterm neonates
    Allegaert, Karel
    Abbasi, Mohammad Yaseen
    Annaert, Pieter
    Olafuyi, Olusola
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2022, 18 (05) : 301 - 312
  • [43] PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING OF ELAGOLIX FOR PREDICTION OF DRUG-DRUG INTERACTIONS (DDIS)
    Chiney, M. S.
    Polepally, A. R.
    Nader, A. M.
    Dufek, M. B.
    Klein, C. E.
    Ng, J. W.
    Shebley, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S59 - S59
  • [44] Evaluating parameter availability for physiologically based pharmacokinetic (PBPK) modeling of perfluorooctanoic acid (PFOA) in zebrafish
    Khazaee, Manoochehr
    Ng, Carla A.
    ENVIRONMENTAL SCIENCE-PROCESSES & IMPACTS, 2018, 20 (01) : 105 - 119
  • [45] APPLICATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING FOR PREDICTION OF BUPRENORPHINE EXPOSURE IN SUBJECTS WITH HEPATIC IMPAIRMENT (HI)
    Rowland-Yeo, K.
    Johnson, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S19 - S19
  • [46] Database for Physiologically Based Pharmacokinetic (PBPK) Modeling: Physiological Data for Healthy and Health-Impaired Elderly
    Thompson, Chad M.
    Johns, Douglas O.
    Sonawane, Babasaheb
    Barton, Hugh A.
    Hattis, Dale
    Tardif, Robert
    Krishnan, Kannan
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2009, 12 (01): : 1 - 24
  • [47] Physiologically based pharmacokinetic (PBPK) modeling of meloxicam in different CYP2C9 genotypes
    Cho, Chang-Keun
    Park, Hye-Jung
    Kang, Pureum
    Moon, Sungmin
    Lee, Yun Jeong
    Bae, Jung-Woo
    Jang, Choon-Gon
    Lee, Seok-Yong
    ARCHIVES OF PHARMACAL RESEARCH, 2021, 44 (12) : 1076 - 1090
  • [48] Physiologically Based Pharmacokinetic (PBPK) Modeling of Pitavastatin and Atorvastatin to Predict Drug-Drug Interactions (DDIs)
    Peng Duan
    Ping Zhao
    Lei Zhang
    European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 689 - 705
  • [49] Utility of physiologically based pharmacokinetic (PBPK) modeling in oncology drug development and its accuracy: a systematic review
    Teerachat Saeheng
    Kesara Na-Bangchang
    Juntra Karbwang
    European Journal of Clinical Pharmacology, 2018, 74 : 1365 - 1376
  • [50] Physiologically Based Pharmacokinetic (PBPK) Modeling of Pitavastatin and Atorvastatin to Predict Drug-Drug Interactions (DDIs)
    Duan, Peng
    Zhao, Ping
    Zhang, Lei
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2017, 42 (04) : 689 - 705
12345